Small scale pharmaceutical companies in Gujarat fail to rake in the moolah through higher export sales realisation as the rupee depreciates. Reason being, major export markets for these units are the non-dollar economies like the African countries. As their overseas clients in these developing countries too are hit by currency fluctuations, demand for drugs has failed to pick up.

Weak Rupee fails to cheer small pharma firms in Guj

Business Standard

Now Maharashtra, Kerala, Karnataka, Andhra Pradesh and Goa would follow Gujarat's model of issuing online product licenses in the bulk drug segment.

Maha, Kerala, keen to follow Gujarat model of online drug licenses

City-based mid-sized pharma player Unimark Remdies has altered its earlier product pipeline of producing an anti-hypertension and anti-cholesterol drug, to focus on developing the active pharmaceutical ingredients (API) of a widely selling anti-biotic amoxycillin through the biocatalysis process.

Unimark alters product pipeline to focus on antibiotic API

Guj-based Unimark alters product pipeline 

Amidst dwindling sales and dealerships downing shutters, e-bike makers are devising strategies to stay afloat in these challenging times.

With dwindling sales, e-bike makers devise strategises to stay afloat

For the second time in a month, a complaint of infringement of patent has been filed against Zydus Pharmaceuticals (USA), a wholly-owned subsidiary of Ahmedabad-based pharma major Cadila Health-care (Zydus Cadila) at a US district court.

Sohini Das